Genetic variation in innate immune response genes contributes to inter-individual differences in disease manifestation and degree of complications upon infection. We recently described an association of single nucleotide polymorphisms (SNPs) in TLR9 with susceptibility to meningococcal meningitis (MM). In this study, we investigate the association of SNPs in multiple pathogen recognition and immune response genes with clinical features that determine severity and outcome (especially hearing loss) of childhood MM and pneumococcal meningitis (PM). Eleven SNPs in seven genes (TLR2, TLR4, TLR9, NOD1, NOD2, CASP1, and TRAIL) were genotyped in 393 survivors of childhood bacterial meningitis (BM) (327 MM patients and 66 PM patients). Genotype distributions of single SNPs and combination of SNPs were compared between thirteen clinical characteristics associated with severity of BM. After correction for multiple testing, TLR4+896 mutant alleles were highly associated with post-meningitis hearing loss, especially MM (p = 0.001, OR 4.0 for BM, p = 0.0004, OR 6.2 for MM). In a multigene analysis, combined carriership of the TLR2+2477 wild type (WT) with TLR4+896 mutant alleles increases the risk of hearing loss (p<0.0001, OR 5.7 in BM and p = 0.0001, OR 7.6 in MM). Carriage of one or both mutant alleles in TLR4+896 and TLR9 -1237 increases the risk for hearing loss (p = 0.0006, OR 4.1 in BM). SNPs in immune response genes contribute to differences in clinical severity and outcome of BM. The TLR system seems to play an important role in the immune response to BM and subsequent neuronal damage as well as in cochlear inflammation. Genetic markers may be used for identification of high-risk patients by creating prediction rules for post-meningitis hearing loss and other sequelae, and provide more insight in the complex immune response in the CNS possibly resulting in new therapeutic interventions.
References
[1]
Chavez-Bueno S, McCracken GH Jr (2005) Bacterial meningitis in children. Pediatr Clin North Am 52: 795–810, vii:
[2]
Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, et al. (2010) Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 10: 317–328. S1473-3099(10)70048-7 [pii]; 10.1016/S1473–3099(10)70048–7 [doi].
[3]
Brouwer MC, Read RC, van de Beek D (2010) Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 10: 262–274. S1473-3099(10)70045-1 [pii]; 10.1016/S1473-3099(10)70045-1 [doi].
[4]
Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, et al. (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175: 4320–4330.
[5]
Sanders MS, van Well GT, Ouburg S, Lundberg PS, van Furth AM, et al. (2011) Single Nucleotide Polymorphisms in TLR9 Are Highly Associated with Susceptibility to Bacterial Meningitis in Children. Clin Infect Dis 52: 475–480. ciq155 [pii]; 10.1093/cid/ciq155 [doi].
[6]
Sanders MS, van Well GT, Ouburg S, Morre SA, van Furth AM (2011) Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis. Genes Immun 12(5): 321–334. gene201120 [pii]; 10.1038/gene.2011.20 [doi].
[7]
Allen A, Obaro S, Bojang K, Awomoyi AA, Greenwood BM, et al. (2003) Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr Infect Dis J 22: 1018–1019.
[8]
Doernberg S, Schaaf B, Dalhoff K, Leng L, Beitin A, et al. (2011) Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae. Cytokine 53(30): 292–294. S1043-4666(10)00781-7 [pii]; 10.1016/j.cyto.2010.12.010 [doi].
[9]
Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, et al. (1999) Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1–5. ji_v163n1p1 [pii].
[10]
Massari P, Visintin A, Gunawardana J, Halmen KA, King CA, et al. (2006) Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J Immunol 176: 2373–2380. 176/4/2373 [pii].
[11]
Echchannaoui H, Frei K, Schnell C, Leib SL, Zimmerli W, et al. (2002) Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 186: 798–806. JID020213 [pii]; 10.1086/342845 [doi].
[12]
Sutherland AM, Walley KR, Russell JA (2005) Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 33: 638–644.
[13]
Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA (2000) A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68: 6398–6401.
[14]
Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187–191.
[15]
Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, et al. (2002) Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186: 1522–1525.
[16]
Faber J, Schuessler T, Finn A, Murdoch C, Zenz W, et al. (2007) Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood. Pediatr Infect Dis J 26: 243–246.
[17]
Faber J, Henninger N, Finn A, Zenz W, Zepp F, et al. (2009) A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease. Acta Paediatr 98: 548–552. APA1163 [pii]; 10.1111/j.1651–2227.2008.01163.x [doi].
[18]
Yuan FF, Marks K, Wong M, Watson S, de Leon E, et al. (2008) Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 86: 268–270.
[19]
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740–745.
[20]
Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, et al. (2010) Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun 78: 865–871. IAI.01110-09 [pii]; 10.1128/IAI.01110-09 [doi].
[21]
Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783–801.
[22]
Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, et al. (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16: 228–231. nm.2087 [pii]; 10.1038/nm.2087 [doi].
[23]
Chauhan VS, Sterka DG Jr, Furr SR, Young AB, Marriott I (2009) NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia 57: 414–423. 10.1002/glia.20770 [doi].
[24]
Liu X, Chauhan VS, Young AB, Marriott I (2010) NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae. Glia 58: 839–847. 10.1002/glia.20968 [doi].
[25]
Abraham C, Cho JH (2006) Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis 12: 641–650.
[26]
Lu WG, Zou YF, Feng XL, Yuan FL, Gu YL, et al. (2010) Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis. World J Gastroenterol 16: 4348–4356.
[27]
Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, et al. (2003) Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124: 140–146. 10.1053/gast.2003.50019 [doi]; S0016508503500270 [pii].
[28]
Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21: 317–337. dxp017 [pii]; 10.1093/intimm/dxp017 [doi].
[29]
Koedel U, Winkler F, Angele B, Fontana A, Flavell RA, et al. (2002) Role of Caspase-1 in experimental pneumococcal meningitis: Evidence from pharmacologic Caspase inhibition and Caspase-1-deficient mice. Ann Neurol 51: 319–329. 10.1002/ana.10103 [pii].
[30]
Blankenberg S, Godefroy T, Poirier O, Rupprecht HJ, Barbaux S, et al. (2006) Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk. Circ Res 99: 102–108.
[31]
Hoffmann O, Priller J, Prozorovski T, Schulze-Topphoff U, Baeva N, et al. (2007) TRAIL limits excessive host immune responses in bacterial meningitis. J Clin Invest 117: 2004–2013.
[32]
Weber A, Wandinger KP, Mueller W, Aktas O, Wengert O, et al. (2004) Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis. J Neuroimmunol 149: 195–201.
[33]
Klein M, Koedel U, Kastenbauer S, Pfister HW (2008) Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment. Infection 36: 2–14.
[34]
Harris JP, Ryan AF (1995) Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg 112: 639–653. S0194-5998(95)70170-2 [pii].
[35]
Koedel U (2009) Toll-like receptors in bacterial meningitis. Curr Top Microbiol Immunol 336: 15–40. 10.1007/978-3-642-00549-7_2 [doi].
[36]
Winter AJ, Comis SD, Osborne MP, Tarlow MJ, Stephen J, et al. (1997) A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun 65: 4411–4418.
[37]
Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, et al. (2008) Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis 198: 1028–1036. 10.1086/591626 [doi].
[38]
Klein M, Schmidt C, Kastenbauer S, Paul R, Kirschning CJ, et al. (2007) MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. J Infect Dis 195: 1189–1193. JID37245 [pii]; 10.1086/512859 [doi].
[39]
Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, et al. (2008) Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14: 346–352. 10.2119/2007-00135.Ferwerda [doi].
[40]
Read RC, Pullin J, Gregory S, Borrow R, Kaczmarski EB, et al. (2001) A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 184: 640–642.
[41]
Ng MT, Van't Hof R, Crockett JC, Hope ME, Berry S, et al. (2010) Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9–1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect Immun 78: 1345–1352. IAI.01226-09 [pii]; 10.1128/IAI.01226-09 [doi].
[42]
Sam-Agudu NA, Greene JA, Opoka RO, Kazura JW, Boivin MJ, et al. (2010) TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg 82: 548–555. 82/4/548 [pii]; 10.4269/ajtmh.2010.09-0467 [doi].
[43]
Mogensen TH, Paludan SR, Kilian M, Ostergaard L (2006) Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukoc Biol 80: 267–277.
[44]
Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, et al. (2003) Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. Pediatrics 112: 1049–1053.
[45]
Koomen I, Grobbee DE, Roord JJ, Jennekens-Schinkel A, van der Lei HD, et al. (2004) Prediction of academic and behavioural limitations in school-age survivors of bacterial meningitis. Acta Paediatr 93: 1378–1385.
[46]
de Jonge RCJ, Sanders MS, Terwee CB, Heymans MB, Gemke RJBJ, et al. (2012) Independent validation of existing model enables robust prediction of hearing loss after bacterial meningitis in childhood (submitted). Pediatrics. In press.
[47]
de Jonge RC, van Furth AM, Wassenaar M, Gemke RJ, Terwee CB (2010) Predicting sequelae and death after bacterial meningitis in childhood: A systematic review of prognostic studies. BMC Infect Dis 10: 232. 1471-2334-10-232 [pii]; 10.1186/1471-2334-10-232 [doi].
[48]
Theiner G, Rossner S, Dalpke A, Bode K, Berger T, et al. (2008) TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. Mol Immunol 45: 244–252.
